Amelioration of muscle wasting by glucagon‐like peptide‐1 receptor agonist in muscle atrophy

Abstract Background Skeletal muscle atrophy is defined as a reduction of muscle mass caused by excessive protein degradation. However, the development of therapeutic interventions is still in an early stage. Although glucagon‐like peptide‐1 receptor (GLP‐1R) agonists, such as exendin‐4 (Ex‐4) and du...

詳細記述

書誌詳細

主要な著者:	Yeonhee Hong, Jong Han Lee, Kwang Won Jeong, Cheol Soo Choi, Hee‐Sook Jun
フォーマット:	Artigo
言語:	Inglês
出版事項:	Wiley 2019-08-01
シリーズ:	Journal of Cachexia, Sarcopenia and Muscle
主題:	Skeletal muscle atrophy GLP‐1R agonists Dexamethasone Glucocorticoid receptor Chronic kidney disease Duchenne muscular dystrophy
オンライン･アクセス:	https://doi.org/10.1002/jcsm.12434
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!